JPH04145017A - Gelatin capsule composition - Google Patents
Gelatin capsule compositionInfo
- Publication number
- JPH04145017A JPH04145017A JP26580990A JP26580990A JPH04145017A JP H04145017 A JPH04145017 A JP H04145017A JP 26580990 A JP26580990 A JP 26580990A JP 26580990 A JP26580990 A JP 26580990A JP H04145017 A JPH04145017 A JP H04145017A
- Authority
- JP
- Japan
- Prior art keywords
- water
- composition
- gelatin
- acid
- solubility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 239000007903 gelatin capsule Substances 0.000 title claims abstract description 13
- 239000003755 preservative agent Substances 0.000 claims abstract 2
- 230000002335 preservative effect Effects 0.000 claims abstract 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract 2
- 239000000049 pigment Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 23
- 108010010803 Gelatin Proteins 0.000 abstract description 17
- 229920000159 gelatin Polymers 0.000 abstract description 17
- 239000008273 gelatin Substances 0.000 abstract description 17
- 235000019322 gelatine Nutrition 0.000 abstract description 17
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 8
- 229920002472 Starch Polymers 0.000 abstract description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000011347 resin Substances 0.000 abstract description 4
- 229920005989 resin Polymers 0.000 abstract description 4
- 239000008107 starch Substances 0.000 abstract description 4
- 235000019698 starch Nutrition 0.000 abstract description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002734 clay mineral Substances 0.000 abstract description 3
- 239000001630 malic acid Substances 0.000 abstract description 3
- 235000011090 malic acid Nutrition 0.000 abstract description 3
- 150000007524 organic acids Chemical class 0.000 abstract description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract description 2
- 229920002125 Sokalan® Polymers 0.000 abstract description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000440 bentonite Substances 0.000 abstract description 2
- 229910000278 bentonite Inorganic materials 0.000 abstract description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004310 lactic acid Substances 0.000 abstract description 2
- 235000014655 lactic acid Nutrition 0.000 abstract description 2
- 229910052901 montmorillonite Inorganic materials 0.000 abstract description 2
- 239000004014 plasticizer Substances 0.000 abstract description 2
- 239000004584 polyacrylic acid Substances 0.000 abstract description 2
- 235000002906 tartaric acid Nutrition 0.000 abstract description 2
- 239000011975 tartaric acid Substances 0.000 abstract description 2
- 239000003086 colorant Substances 0.000 abstract 1
- 230000001976 improved effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 description 21
- 238000004519 manufacturing process Methods 0.000 description 18
- 235000011187 glycerol Nutrition 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 239000008399 tap water Substances 0.000 description 8
- 235000020679 tap water Nutrition 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 150000004645 aluminates Chemical class 0.000 description 2
- 239000007963 capsule composition Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000001052 yellow pigment Substances 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- CYKDLUMZOVATFT-UHFFFAOYSA-N ethenyl acetate;prop-2-enoic acid Chemical compound OC(=O)C=C.CC(=O)OC=C CYKDLUMZOVATFT-UHFFFAOYSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- NEMFQSKAPLGFIP-UHFFFAOYSA-N magnesiosodium Chemical compound [Na].[Mg] NEMFQSKAPLGFIP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は水膨潤性成分を含有するゼラチンカプセル組成
物で、保形安定性及び溶解性に優れ、人体に対して安全
なゼラチンカプセル組成物に関するものであり、例えば
医薬品、医薬部外品、化粧品、食料品及び雑貨品等の分
野で利用されるものである。Detailed Description of the Invention [Field of Industrial Application] The present invention is a gelatin capsule composition containing a water-swellable component, which has excellent shape retention stability and solubility, and is safe for the human body. For example, it is used in the fields of pharmaceuticals, quasi-drugs, cosmetics, foodstuffs, and miscellaneous goods.
医薬品、医薬部外品、化粧品、食料品及び雑貨品の分野
は、中味の保存あるいは、使い易さの点で外側を覆う剤
皮として、ゼラチンカプセルが使用されている。In the fields of pharmaceuticals, quasi-drugs, cosmetics, foodstuffs, and miscellaneous goods, gelatin capsules are used as outer shells for preserving the contents and for ease of use.
通常、用いられているゼラチカプセルの組成は、ゼラチ
ンを主成分として可塑剤にグリセリン及び水が加えられ
たもので、加工、成形及び乾燥したものをセラチンカプ
セル剤皮として使用されている。The composition of the gelatin capsules used is usually gelatin as a main component, with glycerin and water added to a plasticizer, and the gelatin capsules are processed, molded and dried and used as the shell of the seratin capsules.
この様なカプセル剤皮を医薬品、医薬部外品、化粧品、
食料品及び雑貨品に利用する場合、中味の保存、保持及
び使い易さは当然の事ながら、長期間保存しても溶解性
に優れている事が重要なファクターである。このため、
上記目的で使用されるカプセルは保形安定性及びカプセ
ルの溶解性が悪くならない事が要求される。Such capsule shells can be used for pharmaceuticals, quasi-drugs, cosmetics,
When used in foodstuffs and miscellaneous goods, important factors are not only preservation and retention of contents and ease of use, but also excellent solubility even after long-term storage. For this reason,
Capsules used for the above purpose are required to have shape retention stability and capsule solubility that do not deteriorate.
従来のカプセル剤皮としては、特定の剤皮、例えば特開
昭55−138457のセラチン分子中のアミノ基を有
機酸で封鎖したモデファイトゼラチン、特開昭61−1
86314のコハク化セラチンを用いたものがある。し
かしながらこれらの特殊な剤皮を除けば、溶解性に優れ
ているものまたは充分に満たすものは知られていなかっ
た。Conventional capsule shells include specific shells, such as modephite gelatin in which the amino group in the seratin molecule is blocked with an organic acid, disclosed in JP-A-55-138457, and JP-A-61-1.
There is one that uses succinated seratin 86314. However, apart from these special coatings, no coatings with excellent or sufficient solubility have been known.
例えば、密封したカラス及びプラスチイックス容器にカ
プセルを入れて、長期間室温又は高温に放置すると溶解
性が悪くなったり、全く溶けなくなってしまう。For example, if a capsule is placed in a sealed glass or plastic container and left at room temperature or high temperature for a long period of time, the solubility will deteriorate or it will not dissolve at all.
本発明者らは、上記の事情に鑑み、長期間室温又は高温
に放置しても溶解性に優れるカプセルか得られないもの
か鋭意研究した結果、水膨潤性成分を用いたならば上記
問題点が解決できることを見出し本発明を完成するに至
った。In view of the above circumstances, the inventors of the present invention have conducted intensive research to determine whether capsules with excellent solubility can be obtained even if left at room temperature or high temperature for a long period of time, and have found that if a water-swellable component is used, the above problems will be solved. The present invention has been completed based on the discovery that the problem can be solved.
すなわち、本発明は、水膨潤性成分を含有することを特
徴とするゼラチンカプセル組成物を提供するものである
。That is, the present invention provides a gelatin capsule composition characterized by containing a water-swellable component.
以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明で使用される水膨潤性成分としては粘土鉱物、デ
ンプンおよび吸水性樹脂から選ばれる1種または2種以
上が溶解性の点から特に適している。As the water-swellable component used in the present invention, one or more selected from clay minerals, starch, and water-absorbing resins are particularly suitable from the viewpoint of solubility.
粘土鉱物としてはスメクタイト属に属するケイ酸塩鉱物
であり、ケイ酸アルミニウムマグネシウム、ベントナイ
ト、モンモリロナイト、サポナイト、合成ケイ酸ナトリ
ウムマグネシウム、合成メタケイ酸アルミン酸マグネシ
ウム等が挙げられ、天然物または合成物のいずれでもよ
い。デンプンとしては、小麦、米、トウモロコシ、ジャ
ガイモ等から得られるものが挙げられる。高吸水性樹脂
としては自重の10倍以上の吸水量を有するポリアクリ
ル酸塩系、イソブチレン−マレイン酸共重合体系、デン
プン−アクリル酸グラフト共重合体系、酢酸ビニル−ア
クリル酸エステル共重合体系、ポリエチレンオキサイド
系、カルボキシメチルセルロース系等が挙げられる。Clay minerals are silicate minerals belonging to the genus smectite, and include magnesium aluminum silicate, bentonite, montmorillonite, saponite, synthetic sodium magnesium silicate, synthetic magnesium aluminate metasilicate, etc., and may be either natural or synthetic. But that's fine. Examples of starch include those obtained from wheat, rice, corn, potato, and the like. Examples of super absorbent resins include polyacrylates, isobutylene-maleic acid copolymers, starch-acrylic acid graft copolymers, vinyl acetate-acrylic acid ester copolymers, and polyethylene, which absorb more than 10 times its own weight of water. Examples include oxide type and carboxymethyl cellulose type.
これらの水膨潤性成分が、ゼラチンカプセル組成物のゼ
ラチンの網目構造に配列し、飲み薬や健康食品のように
口の中に飲み込んだ時またはお湯に溶かして使用する時
、ゼラチンの網目構造を徐々に破壊し、溶解させるもの
である。These water-swellable ingredients are arranged in the gelatin network structure of the gelatin capsule composition, and when swallowed in the mouth like oral medicine or health food or dissolved in hot water, the gelatin network structure is arranged. It gradually destroys and dissolves.
本発明のゼラチンカプセル組成物への水膨潤性成分の配
合量はセラチンカプセル組成物全量中0.1〜10重量
%となるように配合することか適当である。0,1重量
%未満ではセラチンの網目構造を破壊する力が弱く溶解
促進効果も弱い。10重量%を超えると、ゼラチンの網
目構造が弱くなり、保形安定性が悪くなる。The water-swellable component is suitably added to the gelatin capsule composition of the present invention in an amount of 0.1 to 10% by weight based on the total amount of the seratin capsule composition. If it is less than 0.1% by weight, the power to destroy the network structure of seratin is weak and the dissolution promoting effect is also weak. If it exceeds 10% by weight, the network structure of gelatin will become weak and the shape retention stability will deteriorate.
本発明のセラチンカプセル組成物には、上記した必須成
分の他に、リンゴ酸、酒石酸、乳酸、コハク酸等の有機
酸を組み合わせると効果の面で好ましい。In addition to the above-mentioned essential ingredients, it is preferable to combine organic acids such as malic acid, tartaric acid, lactic acid, and succinic acid in the seratin capsule composition of the present invention in terms of effectiveness.
本発明のゼラチンカプセル組成物は、保形安定性及び溶
解性に優れるものである。The gelatin capsule composition of the present invention has excellent shape retention stability and solubility.
次に、比較例および実施例に基づいて、本発明をさらに
詳細に説明する。本発明はこれらの実施例によって限定
されるものではない。配合量は全て重量%である。Next, the present invention will be explained in more detail based on comparative examples and examples. The present invention is not limited to these examples. All compounding amounts are weight %.
比較例、実施例はそれぞれ次のような製造方法にて得た
。Comparative Examples and Examples were obtained by the following manufacturing methods.
〈製造方法〉
(イ)セラチンの溶解方法
比較例の場合はジャケット式の釜にゼラチン、グリセリ
ン、水を仕込みジャケットに熱湯を通して釜の温度を7
0°Cに加熱し、攪拌しながらゼラチンを溶解した。そ
の後、脱気して、温度を下げて60℃に保った。<Manufacturing method> (a) Method for dissolving seratin In the case of a comparative example, gelatin, glycerin, and water are placed in a jacket-type pot, and boiling water is passed through the jacket to bring the temperature of the pot to 7.
The gelatin was dissolved by heating to 0°C and stirring. Thereafter, it was degassed and the temperature was lowered and maintained at 60°C.
実施例の場合は上記配合成分に加えて、水膨潤性成分を
配合した。In the case of the example, a water-swellable component was blended in addition to the above-mentioned blended components.
(ロ)ゼラチンのシート化及びカプセル化溶解したゼラ
チンは、60℃に保温し、l昼夜放置後、ローラー上で
シート化し、シートは、ロータリー式全自動ソフトカプ
セル成計機の円筒型成型ダイロールに供給し双方向から
の回転により、次つぎに成型され、同時にポンプによっ
て内容液が充填される。内容液が規定量に達すると同時
に成型も完了し、このとき接着に必要な温度は、形状セ
グメントにより、シートに与えられ、ダイロールの圧力
によってカプセルは接着される。ダイロールと充填ポン
プの動きは完全に連動し、内容液のロス、及びカプセル
内への空気の混入は皆無である。また充填ポンプの運転
精度は、充填内容量のバラツキ上3%以内で高収率が実
現出来る。(b) Formation and encapsulation of gelatin The dissolved gelatin is kept at 60°C and left to stand day and night, and then formed into a sheet on a roller.The sheet is fed to a cylindrical molding die roll of a rotary fully automatic soft capsule forming machine. By rotating in both directions, the mold is molded one after the other, and at the same time, the liquid is filled by a pump. Molding is completed as soon as the content liquid reaches a specified amount. At this time, the temperature necessary for adhesion is applied to the sheet by the shaped segments, and the capsules are adhered by the pressure of the die roll. The movements of the die roll and filling pump are completely linked, and there is no loss of liquid content or air getting into the capsule. Furthermore, the operating accuracy of the filling pump is within 3% due to variations in the amount of filling, and high yields can be achieved.
(ハ)内容液
内容液はイソプロピルミリステートにバラの調合香料を
溶解したものを選びカプセル内に包接した。(c) Content liquid The content liquid was a mixture of rose fragrance dissolved in isopropyl myristate and was included in the capsule.
(ニ)カプセルの水分調整
(ロ)で得たカプセルは温度22℃、湿度30%の室に
放置し、カプセル皮膜の水分が3〜12%になるまで乾
燥し、最終のサンプルを得た。(d) Capsule moisture adjustment The capsules obtained in (b) were left in a room at a temperature of 22° C. and a humidity of 30%, and dried until the moisture content of the capsule film became 3 to 12% to obtain a final sample.
なお、比較例および実施例の配合量は、仕込み時の配合
量で水分調整後の最終サンプルの配合量ではない。Note that the blending amounts in Comparative Examples and Examples are the blending amounts at the time of preparation and are not the blending amounts in the final sample after moisture adjustment.
比較例1
(1)ゼラチン
(2)グリセリン
(3)水道水
製造方法
40 %
20 %
40 %
(1)〜(3)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル(flた。Comparative Example 1 (1) Gelatin (2) Glycerin (3) Tap water manufacturing method 40% 20% 40% (1) to (3) were placed in a pot in order, and the above manufacturing methods (a), (b), and (c) were prepared. According to (d), capsules (fl) were prepared.
比較例2
(1)ゼラチン
(2)グリセリン
(3)水道水
(4)黄色色素1号
(5) メチルパラベン
(6)2−ヒドロキシ−4
メトキシ
ベンゾフェノン
40 %
20 %
適量
0.001%
0゜1%
0.1%
製造方法
(1)〜(6)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Comparative Example 2 (1) Gelatin (2) Glycerin (3) Tap water (4) Yellow dye No. 1 (5) Methylparaben (6) 2-hydroxy-4 methoxybenzophenone 40% 20% Appropriate amount 0.001% 0°1% 0.1% Production methods (1) to (6) were charged in order into a pot, and encapsulated according to the production methods (a), (b), (c), and (d).
実施例1
(1)ゼラチン
(2)グリセリン
40 %
20 %
(3)水道水 適 量(4)
ポリアクリル酸系吸水系樹脂 0.1 %(
太陽化学社製パルカス500B)
製造方法
(1)〜(4)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 1 (1) Gelatin (2) Glycerin 40% 20% (3) Appropriate amount of tap water (4)
Polyacrylic acid water absorbent resin 0.1% (
Palcas 500B (manufactured by Taiyo Kagaku Co., Ltd.) Production methods (1) to (4) were placed in a pot in order, and encapsulated according to the production methods (a), (b), (c), and (d).
実施例2
(1)ゼラチン
(2)グリセリン
(3)水道水
(4)黄色色素1号
(5)合成ケイ酸す
40 %
20 %
適量
0.001%
トリウム 5 %
マグネシウム
製造方法
(11〜(5)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 2 (1) Gelatin (2) Glycerin (3) Tap water (4) Yellow pigment No. 1 (5) Synthetic silicic acid 40% 20% Appropriate amount 0.001% Thorium 5% Magnesium production method (11-(5) ) were charged in order into a pot and encapsulated according to the manufacturing methods (a), (b), (c), and (d) above.
実施例3
1)セラチン 40 %2
)グリセリン 20 %3)水道
水 適 量4) 黄色色素1
号 0.(101%5) メチルパ
ラベン 0.1 %6)2−ヒド
ロキシ−4
メトキシベンゾフェノン 0.1 %(7)
合成メタケイ酸アルミン酸 10 %マグネ
シウム
製造方法
(11〜(7)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 3 1) Seratin 40%2
) Glycerin 20% 3) Tap water appropriate amount 4) Yellow pigment 1
No. 0. (101%5) Methylparaben 0.1%6) 2-hydroxy-4 methoxybenzophenone 0.1% (7)
Synthetic Metasilicate Aluminate 10% Magnesium Production Method (11 to (7)) were charged in order into a pot and encapsulated according to the production methods (a), (b), (c), and (d).
実施例4
(11ゼラチン
(2)グリセリン
(3)水道水
(4)バレショデンプン
量
%
製造方法
(1)〜(4)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 4 (11 Gelatin (2) Glycerin (3) Tap water (4) Amount of barley starch % Production methods (1) to (4) were placed in a pot in order, and the production methods (A), (B), and (H) ) (d).
実施例5
(1) ゼラチン 40
%(2) グリセリン(POE 3モル)20
%(3)水道水 適 量(4
) コーンスターチ 1 %(
5) リンゴ酸 1 %
製造方法
(1)〜(5)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 5 (1) Gelatin 40
% (2) Glycerin (POE 3 mol) 20
% (3) Appropriate amount of tap water (4
) Cornstarch 1% (
5) Malic acid 1%
Manufacturing methods (1) to (5) were charged in order into a pot, and encapsulated according to the manufacturing methods (a), (b), (c), and (d).
実施例6
(1)ゼラチン
(2)グリセリン
(3)水道水
40 %
20 %
適量
(4)合成メタケイ酸アルミン酸 1 %ナト
リウム
(5) コーンスターチ 1
%製造方法
(1)〜(5)を順番に釜に仕込み、前記製造方法(イ
)(ロ)(ハ)(ニ)に従い、カプセル化した。Example 6 (1) Gelatin (2) Glycerin (3) Tap water 40% 20% Appropriate amount (4) Synthetic metasilicate aluminate 1% sodium (5) Cornstarch 1
% Production Methods (1) to (5) were charged into a pot in order, and encapsulated according to the production methods (a), (b), (c), and (d).
上記の比較例1.2および実施例1〜6で得た試料の評
価は(11カプセルの形状安定性、(2)カプセルの溶
解性について以下に評価方法で評価した。The samples obtained in Comparative Example 1.2 and Examples 1 to 6 were evaluated using the following evaluation methods for (11) shape stability of capsules and (2) solubility of capsules.
カプセルの形゛安定性
試料を0℃、25℃および40℃の温度に1力月間放置
し、カプセルの形状について肉眼で観察した。評点は以
下の評価基準に従った。Capsule shape/stability Samples were left at temperatures of 0° C., 25° C. and 40° C. for one month, and the shape of the capsules was visually observed. The evaluation was based on the following evaluation criteria.
1:全く変化なし
2:はんの僅か変形が見られる
3:僅か変形が見られる
4:かなり変形が見られる
5:形がくずれている
カプセルの溶解性
試料を0℃、25℃および40℃の温度に8力月間放置
したサンプルを、水温38℃で1分間に120回の攪拌
を加え、溶解の度合いを官能で評価した。1: No change at all 2: Slight deformation of the solder is observed 3: Slight deformation is observed 4: Significant deformation is observed 5: Solubility samples of capsules with misshapen shapes were heated at 0°C, 25°C and 40°C. The sample was left at a temperature of 38° C. for 8 months, then stirred 120 times per minute at a water temperature of 38° C., and the degree of dissolution was sensory evaluated.
評点は以下の評価基準に従った。The evaluation was based on the following evaluation criteria.
1:1〜3分で溶解する 2:4〜7分で溶解する 3:8〜11分で溶解する 4:12〜15分で溶解する 5:はとんど溶解しない 結果を表−1,2に示す。1: Dissolves in 1-3 minutes 2: Dissolves in 4-7 minutes 3: Dissolves in 8-11 minutes 4: Dissolves in 12-15 minutes 5: hardly dissolves The results are shown in Tables 1 and 2.
表−1(カプセルの形状安定性)
(以下余白)
(以下余
白)
表
(カプセルの溶解性)
比較例、実施例から明らかな様に本発明のゼラチンカプ
セル組成物は、形くずれが少なく、溶解性に優れている
。Table 1 (Shape stability of capsules) (Hereinafter in the margin) (Hereinafter in the margins) Table (Solubility of capsules) As is clear from the comparative examples and examples, the gelatin capsule composition of the present invention has less deformation and dissolution. Excellent in sex.
Claims (2)
ンカプセル組成物。(1) A gelatin capsule composition characterized by containing a water-swellable component.
のゼラチンカプセル組成物。(2) Claim 1 containing a pigment, a preservative, and an ultraviolet absorber
gelatin capsule composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26580990A JPH04145017A (en) | 1990-10-03 | 1990-10-03 | Gelatin capsule composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26580990A JPH04145017A (en) | 1990-10-03 | 1990-10-03 | Gelatin capsule composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04145017A true JPH04145017A (en) | 1992-05-19 |
Family
ID=17422352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26580990A Pending JPH04145017A (en) | 1990-10-03 | 1990-10-03 | Gelatin capsule composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04145017A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002326030A (en) * | 2001-05-02 | 2002-11-12 | Ogawa & Co Ltd | Method for preventing crosslinking of coating film of noncrosslinked gelatin capsule |
JP2005529128A (en) * | 2002-04-25 | 2005-09-29 | バナー ファーマキャップス, インコーポレーテッド | Chewable soft capsule |
JP2007522821A (en) * | 2004-02-20 | 2007-08-16 | ティー.エフ.エイチ.パブリケーションズ、インコーポレーテッド | Pet food with enhanced nutritional value |
-
1990
- 1990-10-03 JP JP26580990A patent/JPH04145017A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002326030A (en) * | 2001-05-02 | 2002-11-12 | Ogawa & Co Ltd | Method for preventing crosslinking of coating film of noncrosslinked gelatin capsule |
JP2005529128A (en) * | 2002-04-25 | 2005-09-29 | バナー ファーマキャップス, インコーポレーテッド | Chewable soft capsule |
US8097279B2 (en) | 2002-04-25 | 2012-01-17 | Banner Pharmacaps Inc. | Chewable soft capsule |
US8241665B2 (en) | 2002-04-25 | 2012-08-14 | Banner Pharmacaps, Inc. | Chewable soft capsule |
US8414916B2 (en) | 2002-04-25 | 2013-04-09 | Banner Pharma Caps, Inc. | Chewable soft capsule |
US8765174B2 (en) | 2002-04-25 | 2014-07-01 | Banner Pharmacaps Inc. | Chewable soft capsule |
US9072677B2 (en) | 2002-04-25 | 2015-07-07 | Banner Life Sciences Llc | Chewable soft capsules |
US9668976B2 (en) | 2002-04-25 | 2017-06-06 | Banner Life Sciences, LLC | Chewable soft capsules |
US9861586B2 (en) | 2002-04-25 | 2018-01-09 | Patheon Softgels, LLC | Chewable soft capsules |
US10342763B2 (en) | 2002-04-25 | 2019-07-09 | Patheon Softgels, Inc. | Chewable soft capsules |
JP2007522821A (en) * | 2004-02-20 | 2007-08-16 | ティー.エフ.エイチ.パブリケーションズ、インコーポレーテッド | Pet food with enhanced nutritional value |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1057862B1 (en) | Polymer film compositions for capsules | |
EP1042405B1 (en) | Gelatine compositions | |
ES2240148T3 (en) | COMPOSITIONS IN PULULANO FILM. | |
EP1062274B1 (en) | Polyvinyl alcohol compositions | |
WO2007003113A1 (en) | A composition of raw materials for a plant polyose-containing hollow capsule and the properation method of such capsure | |
JPWO2006082842A1 (en) | Hard capsule with improved solubility | |
CN101885853A (en) | Cured cross-linked glutinous rice flour hydrogel, preparation method and application thereof | |
CA1041905A (en) | Integral solid gel-lattice dosage form of high moisture content | |
JP2000128778A (en) | Soft capsule capable of being unsealed by twisting off | |
WO2020073592A1 (en) | Pullulan empty hard capsule and preparation method therefor | |
JP2000044465A (en) | Soft capsule agent | |
JPH04145017A (en) | Gelatin capsule composition | |
CN107929258A (en) | A kind of plant hollow capsule | |
JPS6110508A (en) | Capsule and its production | |
CN101708173B (en) | Soft capsule and application thereof | |
CN108042505A (en) | A kind of plant hollow capsule for being exclusively used in Cefixime | |
KR20220105944A (en) | Composition for Film-Coating Comprising Bentonite | |
CN112336698A (en) | Rapidly disintegrating vaginal soft capsule composition and preparation method thereof | |
JP2711703B2 (en) | Soft capsule | |
JPS6226214A (en) | Solid bath composition slowly soluble in hot water | |
JPH0761935B2 (en) | Bath additive | |
JPS61207329A (en) | Soft capsule filled with hydrophilic substance | |
JPH04159218A (en) | Gelatin capsule composition | |
JP3800206B2 (en) | Transparent aqueous gel for bath preparation | |
MXPA00002854A (en) | Gelatine compositions |